
Zivo Bioscience, Inc. Common Stock
ZIVO
ZIVO: Zivo Bioscience Inc is a research and development company operating in both the biotech and agtech sectors, with an intellectual property portfolio comprised of proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's pipeline candidates are; Bovine Mastitis, Canine Joint Health, Human Immune Modulation, Human Food Ingredients, and Skin Health.
moreShow ZIVO Financials
Recent trades of ZIVO by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ZIVO's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Methods of modulating immune and inflammatory responses via administration of an algal biomass Jul. 20, 2021
-
Patent Title: Agents and mechanisms for treating hypercholesterolemia Nov. 24, 2020
-
Patent Title: Compounds and methods for affecting cytokines Sep. 08, 2020
-
Patent Title: Compounds and methods for affecting cytokines Mar. 19, 2019
-
Patent Title: Composition and method for affecting cytokines and nf-κb Jan. 01, 2019
Federal grants, loans, and purchases
Followers on ZIVO's company Twitter account
Number of mentions of ZIVO in WallStreetBets Daily Discussion
Recent insights relating to ZIVO
Recent picks made for ZIVO stock on CNBC
ETFs with the largest estimated holdings in ZIVO
Flights by private jets registered to ZIVO